(MedPage Today) — Active surveillance (AS) following a complete clinical response to neoadjuvant chemoradiotherapy was noninferior to standard surgery among patients with esophageal cancer, a phase III cluster-randomized trial showed.
In a modified…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/114741
Author :
Publish date : 2025-03-19 21:40:00
Copyright for syndicated content belongs to the linked Source.
